Your browser doesn't support javascript.
loading
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Guiard, Emeline; Clatot, Florian; Even, Caroline; Perréard, Marion; Abdeddaim, Cyril; Johnson, Alison; Vauléon, Elodie; Rambeau, Audrey.
Affiliation
  • Guiard E; Medical Oncology Department, Centre François Baclesse, Caen, France. Electronic address: emelineguiard@gmail.com.
  • Clatot F; Medical Oncology Department, Centre Henri Becquerel, Rouen, France.
  • Even C; Head and Neck Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
  • Perréard M; Head and Neck Surgery Department, University Hospital, Caen, France.
  • Abdeddaim C; Medical Oncology Department, Centre Oscar Lambret, Lille, France.
  • Johnson A; Medical Oncology Department, Centre François Baclesse, Caen, France.
  • Vauléon E; Medical Oncology Department, Centre Eugène Marquis, Rennes, France.
  • Rambeau A; Medical Oncology Department, Centre François Baclesse, Caen, France.
Eur J Cancer ; 159: 125-132, 2021 12.
Article in En | MEDLINE | ID: mdl-34743067
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Paclitaxel / Docetaxel / Squamous Cell Carcinoma of Head and Neck / Nivolumab / Neoplasm Recurrence, Local Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Paclitaxel / Docetaxel / Squamous Cell Carcinoma of Head and Neck / Nivolumab / Neoplasm Recurrence, Local Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article